Home > Balance Sheet > NATCO PHARMA
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹0.40 Cr₹15 Cr₹8.00 Cr₹1.20 Cr₹1.10 Cr

What is the latest Contingent Liabilities ratio of NATCO PHARMA ?

The latest Contingent Liabilities ratio of NATCO PHARMA is ₹0.40 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹0.40 Cr
Mar2023₹15 Cr
Mar2022₹8.00 Cr
Mar2021₹1.20 Cr
Mar2020₹1.10 Cr

How is Contingent Liabilities of NATCO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2024 ₹0.40 Cr
-97.26
Mar2023 ₹15 Cr
82.50
Mar2022 ₹8.00 Cr
566.67
Mar2021 ₹1.20 Cr
9.09
Mar2020 ₹1.10 Cr -

Compare Contingent Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹17,436.3 Cr 10.2% 13.4% -23.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹402,788.0 Cr -0.6% 0.8% 10.5% Stock Analytics
DIVIS LABORATORIES ₹182,283.0 Cr 3.1% 3.8% 49.2% Stock Analytics
CIPLA ₹121,853.0 Cr 0.4% 2.5% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,914.0 Cr -0.2% 6.4% 20.5% Stock Analytics
DR REDDYS LABORATORIES ₹107,932.0 Cr -0.6% 3.3% 0.1% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

10.2%

13.4%

-23.1%

SENSEX

-0.6%

3.1%

5.3%


You may also like the below Video Courses